Infinity Pharmaceuticals Inc (NASDAQ:INFI)
During the Trading Day
| 18.58 |  -0.88 / -4.52% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 18.54 | -0.04 / -0.22% |
Volume: 5.3K |
Latest INFI News | Press Releases
| Afternoon Market Gainers Jun 18 / Benzinga |
Today’s Trading
| Previous close | 19.46 |
| Today’s open | 19.46 |
| Day’s range | 18.35 - 19.70 |
| Volume | 1,725,645 |
| Average volume (3 months) | 1,837,081 |
| Market cap | $958.3M |
| Dividend yield | -- |
Data as of 4:00pm ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | -13.33% |
| Earnings growth (this year) | -46.54% |
| Earnings growth (next 5 years) | +28.00% |
| Revenue growth (last year) | -49.22% |
| P/E ratio | NM |
| Price/Sales | 23.56 |
| Price/Book | 2.98 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| USNAUSANA Health Science... | -1.66 | -2.23% |
| AUXLAuxilium Pharmaceuti... | -0.38 | -2.19% |
| NBIXNeurocrine Bioscienc... | +0.18 | +1.42% |
| PDLIPDL BioPharma Inc | -0.23 | -2.90% |
Data as of 4:01pm ET, 06/19/2013
Financials
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | -$0.62 |
| Annual revenue (last year) | $47.1M |
| Annual profit (last year) | -$54.0M |
| Net profit margin | -114.54% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Adelene Q. Perkins, MBA |
CFO, Secretary, Treasurer & CAO Lawrence E. Bloch, MD, MBA |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
